|
 |
2008/12/26/FDA APPROVES NEW HEART DEVICE WIRES FROM MEDTRONIC THE ASSOCIATED PRESS/
The page is no longer available. You may want to read the following pages.
A Stangherlin... - American Journal of Physiology- ..., 2011 - Am Physiological Soc Abstract Phosphodiesterases (PDEs) are key enzymes in the c AMP signaling cascade. They convert c AMP in its inactive form 5'-AMP and critically regulate the intensity and the duration of c AMP-mediated signals. Multiple isoforms exist that possess different intracellular ...
SA Shapses... - JAMA: The Journal of the American ..., 2011 - Am Med Assoc1. Author Affiliations: Department of Nutritional Sciences, Obesity Group, Rutgers University, New Brunswick, New Jersey (Dr Shapses); and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Manson).
S Boo, CM Waters... - Nursing Research, 2012 - Background: Accurate estimation of coronary heart disease (CHD) risk is requisite for effective primary prevention of the disease. The Framingham Risk Score is the most commonly used method for estimating 10-year risk for CHD in asymptomatic individuals. ...
S Sendelbach, MO Hearst, PJ Johnson... - ..., 2012 - AIM: To assess differences in Cerebral Performance Category (CPC) in patients who received therapeutic hypothermia post cardiac arrest by time to initiation, time to target temperature, and duration of Therapeutic Hypothermia (TH). METHODS: A secondary ...
R Fiskesund, J Su, I Bulatovic, M Vikstrm... - Results in ..., 2012 - Elsevier Background We have reported that anti-phosphorylcholine (anti-PC) Ig M is a protection marker for human cardiovascular disease (CVD) and atherosclerosis. We here investigate the anti-PC autoantibodies in a well-defined cohort with regard to idiotype, atherosclerosis ...
|
|
|
